Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest update is out from Fuji Pharma Co., Ltd. ( (JP:4554) ).
Fuji Pharma Co., Ltd. has completed the acquisition and cancellation of its 1st Series of Stock Acquisition Rights, initially issued in August 2024, with a total of 23,627 units acquired and cancelled at a cost of 6,379,290 yen. This action is expected to have a negligible impact on the company’s business results for the current fiscal year.
More about Fuji Pharma Co., Ltd.
Average Trading Volume: 61,387
Technical Sentiment Signal: Buy
Current Market Cap: Yen34.3B
For an in-depth examination of 4554 stock, go to TipRanks’ Overview page.